|1.||Pasquale, Elena B: 12 articles (01/2015 - 12/2002)|
|2.||Chen, Jin: 7 articles (02/2015 - 02/2002)|
|3.||Wang, Jiandong: 6 articles (01/2015 - 11/2007)|
|4.||Nagano, Kazuya: 4 articles (01/2015 - 01/2011)|
|5.||Mukai, Yohei: 4 articles (01/2015 - 01/2011)|
|6.||Kamada, Haruhiko: 4 articles (01/2015 - 01/2011)|
|7.||Tsutsumi, Yasuo: 4 articles (01/2015 - 01/2011)|
|8.||Yoshioka, Yasuo: 4 articles (01/2015 - 01/2011)|
|9.||Ma, Henghui: 4 articles (01/2013 - 11/2007)|
|10.||Dong, Yingchun: 4 articles (01/2013 - 01/2009)|
02/01/2012 - "These molecules show promise as probes to study Eph receptor/ephrin biology, as lead compounds for drug development, and as targeting agents to deliver drugs or imaging agents to tumors. "
01/01/2008 - "Together our studies suggest that overexpression of HuR as found in many progressive tumors could be causative for disarranged Eph receptor to ephrin ligand ratios leading to a higher degree of tissue invasiveness."
01/01/2015 - "Eph receptor/ephrin upregulation in cancer cells, the angiogenic vasculature, and injured or diseased tissues also offer opportunities for Eph/ephrin-based targeted drug delivery and imaging. "
07/01/2014 - "EphA2, one member of the Eph receptor family, is widely expressed in multiple aggressive cancers. "
01/15/2014 - "Here, we examined the expression and role of the B-type Eph receptor EphB2 in breast cancers. "
01/01/2008 - "Since it has been reported that the ephrin/Eph receptor system plays important signaling roles in inflammation processes, we attempted to examine ephrinB molecules in T cells and synovial cells derived from RA in this study. "
07/01/2006 - "Putative dual role of ephrin-Eph receptor interactions in inflammation."
01/01/2014 - "Abnormal Eph receptor and ephrin signaling is implicated in a variety of epithelial diseases raising the intriguing possibility that this cell-cell communication pathway can be therapeutically harnessed to normalize epithelial function in pathological settings like cancer or chronic inflammation. "
06/01/2006 - "In this review, we analyze our recent study on the expression of erythropoietin-producing hepatocellular (Eph) receptor kinases and their ligands, ephrins, in LPS-induced systemic inflammation. "
|3.||Breast Neoplasms (Breast Cancer)
01/01/2010 - "The identification of three novel candidates as EPH receptor genes might indicate a link between perturbed compartmentalization of early neoplastic lesions and breast cancer risk and progression. "
05/01/2007 - "This review focuses on EphB4, an Eph receptor that has both tumor-suppressing and tumor-promoting activities in breast cancer. "
08/01/2013 - "In this study, we demonstrate Eph receptor B4 (EphB4), a member of Eph kinase family, a positive regulator of ER-α in human breast cancer cell lines (MCF-7, T-47D and BT-474). "
07/18/2014 - "We recently identified Eph receptor A10 (EphA10) as a novel breast cancer-specific protein. "
12/01/2013 - "Eph receptor A10 (EphA10) is a valuable breast cancer marker that is highly expressed in breast cancer tissues by comparison with normal breast tissues, as we previously reported. "
|4.||Hepatocellular Carcinoma (Hepatoma)
03/01/2013 - "In this study, the expression of metadherin (MTDH) and erythropoietin-producing hepatoma-amplified sequence (Eph) receptor A7 (EphA7) in 96 benign and 108 malignant lesions of gallbladder was determined by immunohistochemistry, and their correlations with pathological features and prognosis were analyzed. "
02/01/2010 - "EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma."
06/01/2013 - "Since erythropoietin-producing hepatoma (Eph)-ephrin bidirectional signalling fine-tunes GSIS from pancreatic beta cells, we investigated Eph receptor tyrosine kinases (RTK) as potential drug targets for selectively increasing GSIS. "
09/01/2010 - "The expression profiles of the erythropoietin producing hepatocellular carcinoma (Eph) receptor family of tyrosine kinases have been previously shown to provide molecular signatures of normal breast cells, breast tumor cells and invasive breast carcinoma cells. "
09/04/2007 - "Erythropoietin-producing hepatoma-amplified sequence (Eph) receptor tyrosine kinases and their cell-surface-bound ligands, the ephrins, function as a unique signaling system triggered by cell-to-cell interaction and have been shown to mediate neurodevelopmental processes. "
01/01/2011 - "The gene for Eph-receptor tyrosinekinase-type A2 (EPHA2) has been shown to be involved in the pathogenesis of age-related cataract (ARC). "
01/01/2013 - "Recent studies have identified the Eph receptor ligand ephrin-A5 as a major contributor to lens development, as mice lacking ephrin-A5 develop abnormal lenses, resulting in cataracts. "
|5.||tyrosine receptor (receptor, tyrosine)
|6.||Ephrin-A5 (Ephrin A5)
|9.||antineoplaston A10 (A 10)
|10.||Ephrin-B1 (Ephrin B1)